NIH-funded research Fellowship grant

Understanding how a specific protein affects kidney cell health

Official title: Elucidating the role of cyclin G-associated kinase as a regulator of podocyte autophagy

Funded at Yale University · NIH-11069009 · Data updated 2026-11-12

This study is looking at how a protein called GAK helps keep important kidney cells healthy, and it’s for people interested in finding new treatments for chronic kidney disease by understanding what happens when GAK is missing.

Quick facts

Grant typeFellowship grant
Study typeNIH-funded research
Funding institutionYale University
NIH-funded
Lab location1 site (New Haven, United States)
Project startFebruary 1, 2025
Project endJanuary 31, 2029
Funding year2025
Award (this year)$34,522
NIH project number1F30DK142452-01
Project IDNIH-11069009 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals with chronic kidney disease or those at risk of developing kidney-related issues.

Less likely to help

Patients with acute kidney injury or those without chronic kidney disease may not benefit from this research.

What this research studies

This research investigates the role of cyclin G-associated kinase (GAK) in maintaining the health of specialized kidney cells called podocytes, which are crucial for kidney function. Using a genetically modified mouse model, the study aims to explore how the absence of GAK leads to podocyte damage and kidney failure. The researchers will measure the process of autophagy, which is essential for cellular maintenance, to understand how GAK influences this process. By uncovering these mechanisms, the research seeks to identify potential new therapies for chronic kidney disease.

Why it matters

Potential benefit: If successful, this research could lead to new treatments that improve kidney health and function for patients with chronic kidney disease.

How similar studies have gone: Previous research has shown promising results in understanding podocyte function and repair mechanisms, indicating that this approach has potential for success.

Where this research is happening

  • Yale University
    New Haven, United States
    Active

Researchers

  • Principal investigator: Bunda, Patricia — Yale University
  • Study coordinator: Bunda, Patricia

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Browse more
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.